| Line Item | 2024-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $117K | -92.3% | -94.0% |
| SG&A Expense | $771K | -48.2% | -68.2% |
| Operating Income | -$888K | +70.4% | +79.7% |
| Net Income | -$877K | +70.8% | +82.6% |
| EPS (Basic) | -$0.10 | +74.4% | +98.1% |
| EPS (Diluted) | -$0.10 | +74.4% | +98.1% |
| Line Item | 2024-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $820K | +2.6% | -74.6% |
| Total Assets | $820K | +2.6% | -74.6% |
| Current Liabilities | $2.3M | +6.9% | -31.1% |
| Total Liabilities | $2.8M | +5.6% | -27.0% |
| Stockholders' Equity | -$1.9M | -6.9% | -259.8% |
| Line Item | 2024-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.0M | — | — |
| Financing Cash Flow | $737K | — | — |